The effects of buprenorphine/naloxone on the fetus when used in Expecting Females are unidentified. Buprenorphine/naloxone did not seem to cause structural abnormalities for the duration of animal research. There was proof of obstructed labor, fetal Dying, neonatal death, and developmental delays in animal research. These benefits can't be applied